Generic Nexium Launched by Mylan

Mylan has launched a generic version of AstraZeneca's proton pump inhibitor (PPI) Nexium.

The generic esomeprazole magnesium delayed-release capsules are available in 20-mg and 40-mg dosage strengths and are indicated to treat gastroesophageal reflux disease in adults and children 1 year and older.

"…We're pleased to provide patients with another affordable treatment option," stated Mylan CEO Heather Bresch. "We look forward to continue delivering on our mission to set new standards in health care."

The first generic version of Nexium was approved by the FDA in January 2015.

The use of esomeprazole has been associated with various stomach problems, including severe diarrhea. Patients who take multiple daily doses of PPIs for extended periods of time may have an increased risk of bone fractures.